.svg){kind=small}
Jul-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Mary's Medicinals is stocked at 955 licensed dispensaries across California, Michigan, and 9 other states, 399 of them in California, with the deepest coverage in Los Angeles, San Diego, Sacramento, San Francisco, and Santa Ana. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
Mary's Medicinals concentrated 77.17% of July 2026 sales in Topical, with Tincture & Sublingual at 22.83%, while Topical fell 15.00% year over year but grew 18.27% month over month, and Tincture & Sublingual declined 2.88% year over year but increased 6.91% month over month. Despite a 12.55% brand-level year-over-year decline and a 15.06% increase in average price to $28.73, the mix shift favored quicker month-over-month recovery in Topical, implying the brand is leaning into price-led, core-category momentum even as longer-term 24-month sales sit 27.09% below prior levels.
Holding rank 1 in Topical in Missouri alongside a 77.17% Topical mix and dual-directionality (Topical -15.00% YoY vs. +18.27% MoM; Tincture & Sublingual -2.88% YoY vs. +6.91% MoM) signals defensible positioning where near-term demand elasticity is positive despite higher pricing. The pattern implies Mary’s Medicinals can maintain a category-led leadership posture by prioritizing Topical depth and selectively supporting Tincture & Sublingual as a stabilizer, using the MoM uplift to offset YoY drag while the price step-up tests how far the brand can trade up without eroding share.
Competitive Landscape
Mary's Medicinals holds rank #2 in CA Topical in July 2026, unchanged from #2 year over year, and unchanged from #2 three months ago, while peak rank hit #2 in July 2026; in contrast, Papa & Barkley stayed at #1 year over year despite a 6.07% sales decline and Buddies remained at #3 with a 50.27% sales increase, as Liquid Flower advanced from #6 to #4 on 60.45% growth. This flat #2 trajectory versus a declining #1 and faster-growing #3 implies a consolidation risk: without share capture catalysts, Mary's Medicinals is positioned to be squeezed between a weakening leader and accelerating challengers.
Notable Products
CBD/THC 1:1 No Fragrance Added Transdermal Relief Cream (1000mg CBD, 1000mg THC, 59.1ml, 2oz) posted the sharpest month-over-month lift at +39.1% while climbing into rank 9, contrasted by CBD/THC 1:1 Relief Transdermal Patch (10mg CBD, 10mg THC) dropping -14.9% at rank 6. The CBD/THC 1:1 Large Colling Action Relief Muscle Freeze (1000mg CBD, 1000mg THC, 3oz) rose +32.9% and holds rank 3, as the CBD/THC/CBN 2:3:1 Formula Transdermal Patch (10mg CBD, 15mg THC, 5mg CBN) improved +16.3% to rank 1. Eight of the top ten are Topical SKUs, and Tincture & Sublingual entries both sit in ranks 7 and 10 with one down -10.4% and the other unreported month-over-month, indicating mix consolidation toward transdermal and cream formats. This pattern implies Mary's Medicinals is concentrating demand in multi-cannabinoid Topicals at higher potencies while legacy patches bifurcate between growth and decline, guiding portfolio emphasis toward creams and performance patches over tinctures.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
